{"id":681,"date":"2020-11-27T07:22:45","date_gmt":"2020-11-27T07:22:45","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=681"},"modified":"2020-11-27T07:22:45","modified_gmt":"2020-11-27T07:22:45","slug":"26-nov-2020-favipiravir-associated-with-significant-clinical-and-laboratory-improvements","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/26-nov-2020-favipiravir-associated-with-significant-clinical-and-laboratory-improvements\/","title":{"rendered":"(26 Nov 2020) Favipiravir- associated with significant clinical and laboratory improvements"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey<\/p>\n<p>https:\/\/doi.org\/10.3906\/sag-2008-33<\/p>\n<p class=\"\">This retrospective descriptive study included patients diagnosed with COVID-19 who presented with or developed severe pneumonia.&nbsp; Forty patients who completed a full course (at least 5 days) of favipiravir were included in the study. At baseline, 30 (75%) patients required treatment for respiratory distress. Thirty three patients (82.5%) were discharged from the hospital with full recovery, 6 patients (15%) died and 1 case (2.5%) was still at the ICU when this paper was written. This study provides relevant information for the treatment of COVID-19, suggesting that favipiravir was associated with significant clinical and laboratory improvements in the majority of the patients, is a safe drug with no serious side effects and would merit further investigation.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey https:\/\/doi.org\/10.3906\/sag-2008-33 This retrospective descriptive study included patients diagnosed with COVID-19 who presented with or developed severe pneumonia.&nbsp; Forty patients who completed a full course (at least&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/26-nov-2020-favipiravir-associated-with-significant-clinical-and-laboratory-improvements\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(26 Nov 2020) Favipiravir- associated with significant clinical and laboratory improvements&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,11],"tags":[26],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/681"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=681"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/681\/revisions"}],"predecessor-version":[{"id":682,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/681\/revisions\/682"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}